May 12 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2022 Mar 31, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 109 mln 89 mln 370 mln
(+22.3 pct) (+20.2 pct) (-10.7 pct)
Operating loss 37 mln loss 50 mln loss 690 mln
Recurring loss 26 mln loss 40 mln loss 700 mln
Net loss 21 mln loss 41 mln loss 670 mln
EPS loss 0.74 yen loss 1.41 yen loss 22.82 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T